🚀 VC round data is live in beta, check it out!
Tecan Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Tecan Group and similar public comparables like MicroPort Scientific, AddLife, Bausch Health, Mehow Innovative and more.
Tecan Group Overview
About Tecan Group
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; The Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, The partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their names. A majority proportion of Tecan's revenue is generated in the Americas and Europe.
Founded
1980
HQ
Employees
3.9K
Website
Financials (LTM)
EV
$2B
Tecan Group Financials
Tecan Group reported last 12-month revenue of $1B and EBITDA of $172M.
In the same LTM period, Tecan Group generated $400M in gross profit, $172M in EBITDA, and had net loss of ($78M).
Revenue (LTM)
Tecan Group P&L
In the most recent fiscal year, Tecan Group reported revenue of $1B and EBITDA of $170M.
Tecan Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $400M | XXX | $398M | XXX | XXX | XXX |
| Gross Margin | 36% | XXX | 35% | XXX | XXX | XXX |
| EBITDA | $172M | XXX | $170M | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| EBIT Margin | 2% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | ($78M) | XXX | ($140M) | XXX | XXX | XXX |
| Net Margin | (7%) | XXX | (12%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Tecan Group Stock Performance
Tecan Group has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Tecan Group's stock price is $176.63.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.2% | XXX | XXX | XXX | $-11.09 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTecan Group Valuation Multiples
Tecan Group trades at 1.9x EV/Revenue multiple, and 12.3x EV/EBITDA.
EV / Revenue (LTM)
Tecan Group Financial Valuation Multiples
As of April 20, 2026, Tecan Group has market cap of $2B and EV of $2B.
Equity research analysts estimate Tecan Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Tecan Group has a P/E ratio of (28.6x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 12.3x | XXX | 12.5x | XXX | XXX | XXX |
| EV/EBIT | 77.7x | XXX | 34.4x | XXX | XXX | XXX |
| EV/Gross Profit | 5.3x | XXX | 5.3x | XXX | XXX | XXX |
| P/E | (28.6x) | XXX | (15.9x) | XXX | XXX | XXX |
| EV/FCF | 15.1x | XXX | 13.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Tecan Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Tecan Group Margins & Growth Rates
Tecan Group's revenue in the last 12 month grew by 2%.
Tecan Group's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Tecan Group's rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Tecan Group's rule of X is 16% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Tecan Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 0% | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 16% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 16% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 13% | XXX | 13% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 10% | XXX | 10% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 8% | XXX | 8% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 30% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Tecan Group Public Comps
See public comps and valuation multiples for other Medical Devices and Laboratory Services comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Tecan Group | XXX | XXX | XXX | XXX | XXX | XXX |
| MicroPort Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| AddLife | XXX | XXX | XXX | XXX | XXX | XXX |
| Bausch Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Mehow Innovative | XXX | XXX | XXX | XXX | XXX | XXX |
| Sinbon Electronics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Tecan Group M&A Activity
Tecan Group acquired XXX companies to date.
Last acquisition by Tecan Group was on XXXXXXXX, XXXXX. Tecan Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Tecan Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialTecan Group Investment Activity
Tecan Group invested in XXX companies to date.
Tecan Group made its latest investment on XXXXXXXX, XXXXX. Tecan Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Tecan Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Tecan Group
| When was Tecan Group founded? | Tecan Group was founded in 1980. |
| Where is Tecan Group headquartered? | Tecan Group is headquartered in Switzerland. |
| How many employees does Tecan Group have? | As of today, Tecan Group has over 3K employees. |
| Is Tecan Group publicly listed? | Yes, Tecan Group is a public company listed on SIX Swiss Exchange. |
| What is the stock symbol of Tecan Group? | Tecan Group trades under TECN ticker. |
| When did Tecan Group go public? | Tecan Group went public in 2001. |
| Who are competitors of Tecan Group? | Tecan Group main competitors are MicroPort Scientific, AddLife, Bausch Health, Mehow Innovative. |
| What is the current market cap of Tecan Group? | Tecan Group's current market cap is $2B. |
| What is the current revenue of Tecan Group? | Tecan Group's last 12 months revenue is $1B. |
| What is the current revenue growth of Tecan Group? | Tecan Group revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Tecan Group? | Current revenue multiple of Tecan Group is 1.9x. |
| Is Tecan Group profitable? | Yes, Tecan Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Tecan Group? | Tecan Group's last 12 months EBITDA is $172M. |
| What is Tecan Group's EBITDA margin? | Tecan Group's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of Tecan Group? | Current EBITDA multiple of Tecan Group is 12.3x. |
| What is the current FCF of Tecan Group? | Tecan Group's last 12 months FCF is $140M. |
| What is Tecan Group's FCF margin? | Tecan Group's last 12 months FCF margin is 12%. |
| What is the current EV/FCF multiple of Tecan Group? | Current FCF multiple of Tecan Group is 15.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.